News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Nano Labs trades at roughly $44M market cap with a P/E near 2.
  • Nano Labs announced product launches and a North America MOU for AI data centers, with insider buying supporting a tactical long thesis.
  • KOSPI surrendered large shares of its AI-led rally after a 33% peak drop, recording sharp monthly and weekly pullbacks.
  • Index concentration in Samsung and SK Hynix and a retail-fueled leveraged ETF surge magnified the selloff.
  • The AI sentiment unwind followed disappointing guidance from an industry peer, raising regional market risk and volatility.

Latest Articles

Compass Therapeutics Shares Plunge After Mixed COMPANION-002 Results

Compass Therapeutics Shares Plunge After Mixed COMPANION-002 Results

Compass Therapeutics stock dropped 80% after the company released data from its COMPANION-002 Phase 2/3 trial of tovecimig in biliary tract cancer. The combination of tovecimig and paclitaxel improved progression-free survival and response rate but did not achieve statistical significance for overall survival, with the analysis confounded by substa…

TSX Futures Slip as Geopolitics and a Heavy Earnings Calendar Loom

TSX Futures Slip as Geopolitics and a Heavy Earnings Calendar Loom

Futures tied to Canada’s principal equity gauge moved lower Monday as investors prepared for a week loaded with quarterly earnings, central bank guidance and persistent geopolitical tensions between the U.S. and Iran that have disrupted crude flows through the Strait of Hormuz. U.S. contracts were mixed, oil prices rose and gold remained subdued ah…

Oncolytics Aligns with FDA on Planned Pivotal Anal Cancer Study

Oncolytics Aligns with FDA on Planned Pivotal Anal Cancer Study

Oncolytics Biotech announced FDA alignment on the design of a pivotal randomized controlled trial for pelareorep in patients with unresectable metastatic squamous cell carcinoma of the anal canal who have exhausted standard treatments. The trial aims to support both accelerated and full approval based on multiple endpoints. Previous studies show pr…

Everforth Director Increases Stake Amidst Rebranding and Market Volatility

Everforth Director Increases Stake Amidst Rebranding and Market Volatility

Jonathan S. Holman, a director at Everforth Inc (NASDAQ:EFOR), has executed a purchase of common stock in the company. The transaction, which was officially documented in a filing with the Securities and Exchange Commission, involved the acquisition of 2,000 shares on April 24, 2026. This move comes at a time when the company is undergoing signific…

New Data Presented at HRS 2026 Show Short-Term Holter Monitoring Misses a Large Proportion of AF Recurrence Post-Ablation and Clinically Significant Arrhythmias in Pregnancy

New Data Presented at HRS 2026 Show Short-Term Holter Monitoring Misses a Large Proportion of AF Recurrence Post-Ablation and Clinically Significant Arrhythmias in Pregnancy

iRhythm Holdings announced new data presented at HRS 2026 showing that short-term Holter monitoring (24-48 hours) misses a significant proportion of atrial fibrillation (AF) recurrences post-ablation and clinically significant arrhythmias during pregnancy. Their Zio ambulatory ECG device, offering continuous monitoring up to 14 days, demonstrated s…

Terns Pharmaceuticals Announces FDA Breakthrough Therapy Designation Granted to TERN-701 for Certain Patients with Chronic Myeloid Leukemia

Terns Pharmaceuticals Announces FDA Breakthrough Therapy Designation Granted to TERN-701 for Certain Patients with Chronic Myeloid Leukemia

Terns Pharmaceuticals announced that the FDA has granted Breakthrough Therapy Designation to TERN-701, an oral allosteric BCR::ABL1 inhibitor targeting adult patients with Philadelphia chromosome-positive chronic myeloid leukemia (CML) in the chronic phase. This designation recognizes TERN-701's potential to offer substantial clinical improvement i…

Mega-cap earnings, oil volatility and the Fed test record-high U.S. stocks

Mega-cap earnings, oil volatility and the Fed test record-high U.S. stocks

U.S. equity benchmarks climbed to record levels as hopes of renewed nuclear talks between Iran and the United States softened risk perceptions, while investors brace for a dense slate of mega-cap earnings and a Federal Reserve decision that could reshape rate expectations. Energy-market developments and forthcoming macro releases add further uncert…

Safe Pro to Demonstrate AI-Powered Mission Planning at U.S. Army Fort Leonard Wood Maneuver Support Center of Excellence Event

Safe Pro to Demonstrate AI-Powered Mission Planning at U.S. Army Fort Leonard Wood Maneuver Support Center of Excellence Event

Safe Pro Group Inc., a Nasdaq-listed AI defense technology firm, will demonstrate its NODE-X AI edge platform and SPOTD threat detection technology at the U.S. Army's 2026 Joint Protection Combined Expo. These advanced AI tools enable rapid drone image processing for mission planning, threat detection, 3D mapping, and enhanced battlefield situation…

Avalyn Strengthens Leadership Team to Support Long-Term Growth with Appointments of Industry Leaders Adam Golden and Frank Salisbury

Avalyn Strengthens Leadership Team to Support Long-Term Growth with Appointments of Industry Leaders Adam Golden and Frank Salisbury

Avalyn Pharma has strengthened its leadership team by appointing Adam Golden as General Counsel and Head of Business Development, and Frank Salisbury as Senior Vice President of Commercial. These hires bring significant legal, business development, and commercial experience to support Avalyn's clinical advancement and upcoming transition to a publi…

Feedonomics Unlocks Agentic Discovery with Agentic Catalog Exports

Feedonomics Unlocks Agentic Discovery with Agentic Catalog Exports

Commerce (Nasdaq: CMRC) has introduced Feedonomics Agentic Catalog Exports (ACE), an enterprise service enabling merchants to syndicate optimized product catalogs to AI-powered agentic discovery platforms such as OpenAI and Google Gemini. This innovation supports enterprises in becoming 'agent-ready' for AI-driven shopping experiences, reducing eng…

Magnite Unveils New AI-Powered Intelligent Assistance and Agentic Execution Capabilities, Empowering Media Owners and Buyers

Magnite Unveils New AI-Powered Intelligent Assistance and Agentic Execution Capabilities, Empowering Media Owners and Buyers

Magnite announced a significant upgrade of its AI-powered features in its SpringServe platform, introducing intelligent mediation tools such as anomaly detection, demand path optimization, and dynamic pricing to enhance media owners' monetization strategies. Concurrently, Magnite is advancing AI-driven buyer agent tools to streamline campaign activ…

SBC Medical Announces Full-Scale Rollout of Aesthetic Healthcare-Focused Interpretation App "Talk Bridge" Across All Shonan Beauty Clinic Locations

SBC Medical Announces Full-Scale Rollout of Aesthetic Healthcare-Focused Interpretation App "Talk Bridge" Across All Shonan Beauty Clinic Locations

SBC Medical Group Holdings Incorporated announces the full rollout of its aesthetic healthcare interpretation app "Talk Bridge" across all Shonan Beauty Clinic locations. The initiative enhances English-speaking customer support with in-house interpretation services, the creation of the Global Beauty Advisor role, and upgraded English digital marke…